Declaration Under the PREP Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020; effective Feb. 4, 2020)

The record

Jurisdiction

United States

Level

Federal

Authority

Public Readiness and Emergency Preparedness Act, PHS Act § 319F-3 (42 U.S.C. § 247d-6d)

Issued

2020-03-10 Mar. 10, 2020

Effective

2020-02-04 ('The Declaration was effective as of February 4, 2020') (read as 2020-02-04)

End

effective period through October 1, 2024 (§ XII, as amended) (read as 2024-10-01)

In force

Feb. 4, 2020 to Oct. 1, 2024

Quarters

2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3

2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3

Limitation types

Emergency declarationHealth care orders

Addressees

• manufacturers, distributors, program planners and qualified persons administering covered countermeasures (tests, PPE, vaccines, treatments)

Functions reached

• context: the federal legal framework under which pharmacies, employers' clinics, and later dental and other practitioners administered tests and vaccines

Collection

Federal health, safety and transport layer FED-A

Operative words

The Public Readiness and Emergency Preparedness Act (PREP Act) authorizes the Secretary of Health and Human Services (the Secretary) to issue a Declaration to provide liability immunity to certain individuals and entities (Covered Persons) against any claim of loss caused by, arising out of, relating to, or resulting from the manufacture, distribution, administration, or use of medical countermeasures (Covered Countermeasures), except for claims involving 'willful misconduct' as defined in the PREP Act.... DATES: The Declaration was effective as of February 4, 2020.

Enforcement

Notes